Harvard Diabetes Comorbidities and Complications 2023 (Videos)

$70.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

Categories: Endocrine and Nutrition COURSES, Internal Medicine Tags: Endocrine and Nutrition COURSES, Internal Medicine

Description

Harvard Diabetes Comorbidities and Complications 2023 (Videos)

Harvard Diabetes Comorbidities and Complications 2023 Comprehensive Updates for State-of-the-Art Diagnosis, Management, and Prevention Diabetes Comorbidities and Complications will be held online, using live streaming, electronic Q&A, and other remote learning technologies. In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations

This comprehensive course provides education and updates to optimize your care of patients with diabetes and these conditions:
- Obesity
- Cardiovascular Disease
- Heart Failure
- Coronary Artery Disease
- Cerebrovascular Disease
- Hypertension
- Hyperglycemia
- Hypoglycemia
- Dyslipidemia
- Metabolic-Associated Fatty Liver Disease
- Chronic Kidney Disease

Sessions are led by experts in these conditions and their impact on the patient with diabetes. Faculty deliver practical education that is focused on:

Advancing your knowledge of diabetes comorbidities and complications
Delivering state-of-the-art approaches to evaluation and management of the patient with diabetes and these conditions
Identifying practical strategies to reduce the risk of diabetes comorbidities and complications
Optimizing clinical decision-making
Improving patient outcomes

In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations to incorporate the vast number of recent updates covered in this program into day-to-day clinical practice.

EDUCATIONAL HIGHLIGHTS

This program provides strategies, updates, and new practice recommendations to improve your care of patients with (and at risk for) diabetes complications and comorbidities. Participants can rely on this program for updates that ensure state-of-the-art:

PREVENTION and RISK REDUCTION
DIAGNOSIS
MANAGEMENT
USE of the NEWEST DIABETES DRUGS, TECHNOLOGIES, and DEVICES

PREVENTION and RISK REDUCTION

New algorithms for evaluating cardiovascular and renal risk in patients with diabetes
Medical treatment and lifestyle interventions to prevent:
- Cardiovascular disease
- Kidney disease
- Cerebrovascular disease
- Hyper- and hypoglycemia
Medication interactions: avoiding adverse outcomes
Impact of the newest pharmacological tools to reduce CV and renal disease development and progression

DIAGNOSIS

Expanded options for diagnosis of:

Coronary artery disease
Heart failure
Cerebrovascular disease
Chronic kidney disease
Metabolic-associated fatty liver disease
Hypoglycemia

MANAGEMENT

Adjusting pharmacological therapies in the patient with diabetes complications
Evaluating, managing, and monitoring diabetic CKD
Obesity management: when to consider new therapeutic and surgical options
Diagnosis and management of coronary artery disease in the patient with diabetes
Management of kidney disease in the patient with diabetes
Hypertension and cholesterol management: customizing targets and treatment strategies for each patient
Heart failure: improving patient functional capacity with combined therapies
Management of cerebrovascular disease
Updates in the management of hyper- and hypoglycemia
Current guidelines for treating metabolic-associated fatty liver disease
Combining innovative therapeutic combinations with traditional approaches
Strategies to assess and manage interacting comorbidities

INCORPORATING NEW DRUGS, TECHNOLOGIES, and DEVICES INTO PRACTICE

The expanded roles of SGLT-2 inhibitors, MRA, and GLP-1 RA in treating CV and renal disease
Practical recommendations for the use of GLP-1 RA, SGLT-2 inhibitors, and MRA
Advances in glucose monitors, insulin pumps, and diabetes apps

SOCIAL, RACIAL, SEXUAL, and CULTURAL DIFFERENCES IN DIABETES CARE NEEDS

We are committed to offering the best practices for health care equity and the needs of diverse patient populations. Highlights include:

Management of diabetes and related disorders in diverse racial/ethnic populations
Recognizing biases: strategies for achieving equity and addressing disparities
Establishing and maintaining connections with patients

This CME program will be held online using live streaming, electronic Q&A, and other remote learning technologies.

Monday, July 31, 2023

Welcome and Introduction

A. Enrique Caballero, MD and Romela Petrosyan, MD

OBESITY MANAGEMENT

Medical Treatment of Obesity: Updates and Best Practices for Individualizing Therapies
Bartolome Burguera, MD

Advances in Surgical Treatment of Obesity and Why and When to Refer Patients with Diabetes
Philip Schauer, MD

Q & A and Clinical Case Discussion
Bartolome Burguera, MD and Philip Schauer, MD

Concurrent Breakout Sessions

Choose either of the two breakout sessions listed below
Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

CARDIOVASCULAR –

Diagnosis and Management of Heart Failure in the Patient with Diabetes: What Every Physician Now Needs to Know
Akshay Desai, MD

METABOLIC – Updates in Continuous Glucose Monitoring and Insulin Pumps in Diabetes Management
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

ADVANCES in HYPERTENSION MANAGEMENT

Hypertension Management in the Patient with Diabetes: A Practical Approach
Naomi Fisher, MD

Wrap-Up of Day 1
Course Directors

Tuesday, August 1, 2023

Welcome and Introduction to Day 2 Activities
A. Enrique Caballero, MD and Romela Petrosyan, MD

UPDATES in DIABETES MANAGEMENT

Adjusting Pharmacological Therapies in the Patient with Diabetes Complications
Marie McDonnell, MD

Updates in the Prevention and Management of Hypoglycemia
Devin Steenkamp, MD

Q & A and Clinical Case Discussion
Marie McDonnell, MD and Devin Steenkamp, MD

Concurrent Breakout Sessions

Choose either of the two breakout sessions listed below
Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

CARDIOVASCULAR – Diagnosis and Management of Coronary Artery Disease in the Patient with Diabetes: Practical Tools for the Busy Clinician
Christopher Cannon, MD

METABOLIC – Weight Variability and Diabetes Complications
Antonio Ceriello, MD

ADVANCES in the MANAGEMENT of DYSLIPIDEMIA

Updates, Innovations, and Advances for the Management of Dyslipidemia in the Patient with Diabetes
Om Ganda, MD
Wrap-Up of Day 2
Course Directors

Wednesday, August 2, 2023

Welcome and Introduction to Day 3 Activities
A. Enrique Caballero, MD and Romela Petrosyan, MD

UPDATES for CARDIOVASCULAR and RENAL RISK REDUCTION

in the PATIENT with DIABETES
Practical Recommendations for the Use of GLP-1 RA in Clinical Practice and Their Impact on CV and Renal Risk Reduction
Vanita Aroda, MD

KEYNOTE: The Expanded Role of SGLT-2 Inhibitors in Diabetes, Cardiovascular, and Renal Disease: Implications for Clinical Practice
Deepak Bhatt, MD

KEYNOTE: The Role of MRA Antagonists in CV and Renal Risk Reduction in the Patient with Diabetes: Recent Data and Practical Implications
George Bakris, MD

Q & A and Clinical Case Discussion
Vanita Aroda, MD, Deepak Bhatt, MD, and George Bakris, MD

Concurrent Breakout Sessions

Choose either of the two breakout sessions listed below
Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

CARDIOVASCULAR – Updates in the Evaluation and Management of Peripheral Vascular Disease in the Patient with Diabetes
Allen D. Hamdan, MD

METABOLIC – Diabetes in Pregnancy: New Diagnosis and Treatment Guidelines
Florence Brown, MD

THE EDWARD S. HORTON LECTURE

Management of Diabetes and Related Disorders in Diverse Racial/Ethnic Populations
A. Enrique Caballero, MD

Wrap-Up of Day 3
Course Directors

Thursday, August 3, 2023

Welcome and Introduction to Day 4 Activities
A. Enrique Caballero, MD and Romela Petrosyan, MD

CHRONIC KIDNEY DISEASE

in the PATIENT with DIABETES
Evaluation and Monitoring of Diabetic CKD
Romela Petrosyan, MD
KEYNOTE: Current Clinical Guidelines for the Management of CKD in Diabetes
Katherine R. Tuttle, MD, FASN, FACP, FNKF

Q & A and Clinical Case Discussion
Romela Petrosyan, MD and Katherine R. Tuttle, MD, FASN, FACP, FNKF

Concurrent Breakout Sessions

Choose either of the two breakout sessions listed below
Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

CARDIOVASCULAR – Evaluation and Management of Sexual Dysfunction in Patients with Diabetes
Martin N. Kathrins, MD

METABOLIC – Updates and Best Practices for State-of-the-Art Insulin Therapy
Guillermo Umpierrez, MD

ADVANCES in NON-ALCOHOLIC FATTY LIVER DISEASE

Diagnosis and Management of Non-Alcoholic Fatty Liver Disease
Ken Cusi, MD

Closing Remarks
Course Directors

Harvard Diabetes Comorbidities and Complications 2023 (Videos)